PDE3A Antikörper
-
- Target Alle PDE3A Antikörper anzeigen
- PDE3A (phosphodiesterase 3A, cGMP-Inhibited (PDE3A))
-
Reaktivität
- Human, Ratte, Maus, Affe, Xenopus laevis
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PDE3A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP), ELISA
- Aufreinigung
- Affinity Purified
- Immunogen
- Synthetic peptide selective only for PDE3A variants
- Isotyp
- IgG
- Top Product
- Discover our top product PDE3A Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.72 μg/μL
-
-
Caveolae compartmentalise β2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte." in: Journal of molecular and cellular cardiology, Vol. 52, Issue 2, pp. 388-400, (2012) (PubMed).
: "
-
Caveolae compartmentalise β2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte." in: Journal of molecular and cellular cardiology, Vol. 52, Issue 2, pp. 388-400, (2012) (PubMed).
-
- Target
- PDE3A (phosphodiesterase 3A, cGMP-Inhibited (PDE3A))
- Andere Bezeichnung
- PDE3A (PDE3A Produkte)
- UniProt
- Q14432
- Pathways
- cAMP Metabolic Process
-